Ibrutinib Combined with Immunochemotherapy with or Without Autologous Stem-Cell Transplantation Versus Immunochemotherapy and Autologous Stem-Cell Transplantation in Previously Untreated Patients with Mantle Cell Lymphoma (TRIANGLE): a Three-Arm, Randomised, Open-Label, Phase 3 Superiority Trial of the European Mantle Cell Lymphoma Network